BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30247463)

  • 21. Development of an
    Lee J; Shin D; Roh JL
    Theranostics; 2018; 8(14):3964-3973. PubMed ID: 30083273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale pharmacological profiling of 3D tumor models of cancer cells.
    Mathews Griner LA; Zhang X; Guha R; McKnight C; Goldlust IS; Lal-Nag M; Wilson K; Michael S; Titus S; Shinn P; Thomas CJ; Ferrer M
    Cell Death Dis; 2016 Dec; 7(12):e2492. PubMed ID: 27906188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
    Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
    Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applicability of tumor spheroids for
    Hamilton G; Rath B
    Expert Opin Drug Metab Toxicol; 2019 Jan; 15(1):15-23. PubMed ID: 30484335
    [No Abstract]   [Full Text] [Related]  

  • 25. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
    Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
    Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids.
    Madoux F; Tanner A; Vessels M; Willetts L; Hou S; Scampavia L; Spicer TP
    SLAS Discov; 2017 Jun; 22(5):516-524. PubMed ID: 28346088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity.
    Sherman H; Gitschier HJ; Rossi AE
    Front Immunol; 2018; 9():857. PubMed ID: 29740450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug screening of biopsy-derived spheroids using a self-generated microfluidic concentration gradient.
    Mulholland T; McAllister M; Patek S; Flint D; Underwood M; Sim A; Edwards J; Zagnoni M
    Sci Rep; 2018 Oct; 8(1):14672. PubMed ID: 30279484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
    Lee JM; Park DY; Yang L; Kim EJ; Ahrberg CD; Lee KB; Chung BG
    Sci Rep; 2018 Nov; 8(1):17145. PubMed ID: 30464248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
    Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
    J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of Uniform Spheroid Formation in 384-Well Plates: The Effect of Medium Evaporation.
    Das V; Fürst T; Gurská S; Džubák P; Hajdúch M
    J Biomol Screen; 2016 Oct; 21(9):923-30. PubMed ID: 27226477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates.
    Close DA; Camarco DP; Shan F; Kochanek SJ; Johnston PA
    Methods Mol Biol; 2018; 1683():355-369. PubMed ID: 29082502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development, validation and pilot screening of an in vitro multi-cellular three-dimensional cancer spheroid assay for anti-cancer drug testing.
    Lama R; Zhang L; Naim JM; Williams J; Zhou A; Su B
    Bioorg Med Chem; 2013 Feb; 21(4):922-31. PubMed ID: 23306053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robotic printing and drug testing of 384-well tumor spheroids.
    Ham SL; Thakuri PS; Tavana H
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():2183-6. PubMed ID: 26736723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multicellular tumor spheroid model for high-throughput cancer drug discovery.
    LaBarbera DV; Reid BG; Yoo BH
    Expert Opin Drug Discov; 2012 Sep; 7(9):819-30. PubMed ID: 22788761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-Time Apoptosis and Viability High-Throughput Screening of 3D Multicellular Tumor Spheroids Using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Qiu J; Chan LL
    SLAS Discov; 2018 Feb; 23(2):202-210. PubMed ID: 28915356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
    Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
    Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Issues with Cancer Spheroid Models in Therapeutic Drug Screening.
    Fröhlich E
    Curr Pharm Des; 2020; 26(18):2137-2148. PubMed ID: 32067603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.